Leaflet: Information for the user
Angifen 8.75 mg orange-flavored lozenges
Flurbiprofen
Read this leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor, pharmacist, or nurse.
Contents of the leaflet
Angifen contains flurbiprofen. Flurbiprofen belongs to a group of medications called non-steroidal anti-inflammatory drugs (NSAIDs) that have analgesic and anti-inflammatory properties for the treatment of sore throat. These medications work by modifying the body's response to pain, inflammation, and fever.
Angifen is used for the short-term relief of sore throat symptoms such as irritation, pain, and inflammation, and difficulty swallowing in adults and children over 12 years old.
You should consult a doctor if your symptoms worsen or do not improve after 3 days of treatment.
Do not take Angifen
Warnings and precautions
Consult your doctor or pharmacist before starting to take Angifen:
Avoid concomitant use of two or more NSAIDs or corticosteroids (such as celecoxib, ibuprofen, diclofenac sodium, or prednisolone), as they may increase the risk of side effects, particularly gastrointestinal ones such as ulcers and bleeding (see the "Taking Angifen with other medications" section below).
Infections
Non-steroidal anti-inflammatory medications (NSAIDs) may hide signs of infection such as fever and pain. This may delay the start of appropriate treatment for the infection, which may lead to a higher risk of complications. If you take this medication while having an infection and your symptoms persist or worsen, consult your doctor or pharmacist without delay.
While taking Angifen
Children and adolescents
This medication should not be used by children and adolescents under 12 years old.
Other medications and Angifen
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take another medication, including medications without a prescription. In particular, if you are taking:
Taking Angifen with food, drinks, and alcohol
Alcohol consumption should be avoided during treatment with Angifen, as it may increase the risk of stomach or intestinal bleeding.
Pregnancy, breastfeeding, and fertility
Oral forms (e.g., tablets) of flurbiprofen may cause adverse effects in unborn babies. It is unknown if there is the same risk with Angifen.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before taking this medication. Do not use Angifen if you are in the last trimester of pregnancy. You should not take Angifen during the first six months of pregnancy unless it is clearly necessary and advised by your doctor. If you need treatment during this period, you should use the lowest possible dose and for the shortest possible time.
Flurbiprofen belongs to a group of medications that may affect fertility in women. This effect is reversible when the medication is stopped. It is unlikely that occasional use of this medication can affect your chances of getting pregnant; however, inform your doctor before taking this medication if you have problems conceiving.
Driving and using machines
This medication should not affect your ability to drive and use machines. However, if you experience adverse reactions such as dizziness and/or visual disturbances, do not drive or use machines.
Angifen contains isomalt and maltitol
If your doctor has told you that you have an intolerance to certain sugars, consult your doctor before taking this medication.
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Use the lowest effective dose for the shortest necessary time to relieve symptoms. If you have an infection, consult a doctor or pharmacist without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
The recommended dose is:
Adults and children over 12 years old:
Method of administration:
Oral
Dissolve the lozenge slowly in the mouth, do not swallow it, and do not chew it.
Always move the lozenge around in the mouth while it dissolves.
Use in children:
Children under 12 years old should not take this medication.
These lozenges are for short-term treatment only.
Take the minimum number of lozenges you need for the shortest possible time to relieve your symptoms. If mouth irritation occurs, you should stop treatment with the medication.
Do not take Angifen for more than 3 days.If you do not improve, if your symptoms worsen, or if new symptoms appear, consult your doctor or pharmacist.
If you take more Angifen than you should
Call a doctor or pharmacist or go to the nearest hospital immediately. Symptoms of overdose may include: nausea or vomiting, stomach pain, or, more rarely, diarrhea. You may also experience ringing in the ears, headache, and gastrointestinal bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone may experience them.
STOP TAKINGthis medication and consult your doctor immediately if you develop:
Inform your doctor or pharmacist if you notice any of the following effects or any effect not described in this leaflet:
The following side effects may occur:
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from the available data)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use (www.notificaram.es). By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging and on the blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Angifen
The active ingredient is flurbiprofen. Each lozenge contains 8.75 mg of flurbiprofen.
The other components are:
Isomalt (E 953)
Maltitol (E 965)
Potassium acesulfame (E 950)
Macrogol 300 (E 1521)
Orange flavor (Limonene (50.0%-100%), decanal (0.0%-10%) citral, citronellol (0.1%-1.0%))
Potassium hydroxide (E 525)
Levomenthol
Appearance of the product and package contents
Angifen 8.75 mg orange-flavored lozenges are presented as round lozenges, light yellow to yellowish in color, with a diameter of 19±1 mm, with an orange flavor.
The lozenges are available in PVC-PVDC/Aluminum blisters in printed cardboard boxes or child-resistant PVC-PVDC/Aluminum blisters in printed cardboard boxes.
Package size: 8, 12, 16, 20, or 24 lozenges.
Only some package sizes may be marketed.
Marketing authorization holder
Alfasigma España, S.L.
Avda. Diagonal, 490
08006 Barcelona, SPAIN
Manufacturer
Lozy’s Pharmaceuticals, S.L.
Campus Empresarial s/n
31795 Lekaroz, Navarra
SPAIN
Date of the last revision of this leaflet:October 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es